Children’s National Hospital Washington celebrates UAE’s pioneering healthcare innovations
International partnership drives advances in precision medicine, genetic screening and paediatric care across the Emirates
The United Arab Emirates stands at the forefront of healthcare innovation, according to Dr. Karen Smith, Executive Medical Director of Global Services at Children’s National Hospital in Washington, DC, who has praised the nation’s remarkable progress in precision medicine and advanced therapeutic interventions.
Speaking during the Abu Dhabi Future Health Summit 2026, Dr. Smith underscored the transformative impact of collaborative partnerships between leading international institutions and the UAE’s healthcare infrastructure. These distinguished collaborations have yielded significant advances in genetic screening for newborns and specialised nursing training programmes that elevate the standards of paediatric care throughout the region.
A particularly noteworthy development involves comprehensive whole-exome sequencing for newborns, conducted through cooperation with the Department of Health – Abu Dhabi. This sophisticated diagnostic approach identifies potential medical conditions, facilitates early intervention and enables tailored preventive care strategies, exemplifying the nation’s commitment to proactive healthcare excellence.
The relationship between Children’s National Hospital and UAE healthcare institutions spans more than three decades, demonstrating an enduring commitment to advancing paediatric medicine across borders. This longstanding partnership encompasses cooperation with various hospitals and government entities throughout the Emirates.
A particularly innovative initiative commenced in June 2026 at Al Jalila Children’s Hospital in Dubai, whereby specialised nurses in Washington provide remote monitoring services to the Cardiac Intensive Care Unit during overnight hours in the UAE. This groundbreaking arrangement enhances patient safety, provides additional clinical support and offers consultative expertise to the dedicated teams managing critical paediatric cardiac cases.
Dr. Smith highlighted the hospital’s pioneering research into paediatric brain tumours, which has generated considerable international interest and collaborative research opportunities. Furthermore, advances in gene therapy have demonstrated remarkable therapeutic potential, with successful applications in treating adolescents with sickle cell disease, muscular dystrophy and beta thalassaemia.
The excellence of Children’s National Hospital’s specialised epilepsy surgery programme for paediatric patients has yielded transformative outcomes, including cases where young patients have discontinued anti-seizure medications entirely and now enjoy robust health and wellbeing.
These achievements underscore the UAE’s position as a destination for advanced medical innovation and international healthcare collaboration, attracting renowned institutions committed to advancing the frontiers of paediatric medicine and improving outcomes for children globally.
Source: WAM